Credits Available: 4.50 AMA PRA Category 1 Credit™ & 4.50 MOC points

Description: Immunotherapy, which has demonstrated benefits in advanced and metastatic settings, is moving into early non-small cell lung cancer treatment, expanding options for patients with resected or resectable early-stage non-small cell lung cancer. This rapid evolution of the early NSCLC treatment landscape, while exciting, has created clinical challenges as health care providers struggle with translating these clinical trial results into real-world clinical practices in the adjuvant and neoadjuvant settings. This educational initiative establishes impactful small group interactions among oncology care providers that will, through a variety of collaborative educational experiences, help them optimize the care of their patients with early-stage NSCLC.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse, Nurse Practitioner, Physician Assistant
Target Specialties: Oncology

Megan Fonteno

MD Anderson Cancer Center
Clinical Pharmacy Specialist

My name is Megan Fonteno, PharmD. I completed two years of post graduate school residency at Columbus Regional hospital for year one and University of Utah’s Huntsman Cancer Institute for my oncology second year. I attended Auburn University for Pharmacy School and currently practice as a Melanoma/Sarcoma Pharmacist Specialist at MD Anderson Cancer Center.